To the Editor: In October 2013, the Australian Broadcasting Corporation television program Catalyst featured a two-part documentary series entitled Heart of the matter. The first episode questioned the role of dietary saturated fat in the development of heart disease, and the second debated the use of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as a suitable treatment for hypercholesterolaemia.1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
No relevant disclosures.